We've found
31,654
archived clinical trials in
Cardiology
We've found
31,654
archived clinical trials in
Cardiology
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Status: Enrolling
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Status: Enrolling
Updated: 11/28/2017
Click here to add this to my saved trials
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Status: Enrolling
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Status: Enrolling
Updated: 11/28/2017
Click here to add this to my saved trials
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Status: Enrolling
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Status: Enrolling
Updated: 11/28/2017
Click here to add this to my saved trials
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Status: Enrolling
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Status: Enrolling
Updated: 11/28/2017
Click here to add this to my saved trials
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Status: Enrolling
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Status: Enrolling
Updated: 11/28/2017
Click here to add this to my saved trials
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Status: Enrolling
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Status: Enrolling
Updated: 11/28/2017
Click here to add this to my saved trials
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Status: Enrolling
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Status: Enrolling
Updated: 11/28/2017
Click here to add this to my saved trials
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Status: Enrolling
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Status: Enrolling
Updated: 11/28/2017
Click here to add this to my saved trials
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Status: Enrolling
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Status: Enrolling
Updated: 11/28/2017
Click here to add this to my saved trials
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Status: Enrolling
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Status: Enrolling
Updated: 11/28/2017
Click here to add this to my saved trials
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Status: Enrolling
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Status: Enrolling
Updated: 11/28/2017
Click here to add this to my saved trials
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Status: Enrolling
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Status: Enrolling
Updated: 11/28/2017
Click here to add this to my saved trials
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Status: Enrolling
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Updated: 11/28/2017
Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study
Status: Enrolling
Updated: 11/28/2017
Click here to add this to my saved trials
Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients
Updated: 11/29/2017
A Prospective Randomized Controlled Trial of Hydroxychloroquine in the Primary Thrombosis Prophylaxis of aPL Positive But Thrombosis-free Patients.
Status: Enrolling
Updated: 11/29/2017
Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients
Updated: 11/29/2017
A Prospective Randomized Controlled Trial of Hydroxychloroquine in the Primary Thrombosis Prophylaxis of aPL Positive But Thrombosis-free Patients.
Status: Enrolling
Updated: 11/29/2017
Click here to add this to my saved trials
Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGF
Updated: 11/29/2017
Dexamethasone Intravitreal Implant for Retinal Vein Occlusion Associated Macular Edema After Treatment Failure With Anti-VEGF Medications
Status: Enrolling
Updated: 11/29/2017
Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGF
Updated: 11/29/2017
Dexamethasone Intravitreal Implant for Retinal Vein Occlusion Associated Macular Edema After Treatment Failure With Anti-VEGF Medications
Status: Enrolling
Updated: 11/29/2017
Click here to add this to my saved trials
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
Click here to add this to my saved trials
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
Click here to add this to my saved trials
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
Click here to add this to my saved trials
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
Click here to add this to my saved trials
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
Click here to add this to my saved trials
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
Click here to add this to my saved trials
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
Click here to add this to my saved trials
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
Click here to add this to my saved trials
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
Click here to add this to my saved trials
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
Click here to add this to my saved trials
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
Click here to add this to my saved trials
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
Click here to add this to my saved trials
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
Click here to add this to my saved trials
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
Click here to add this to my saved trials
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
Click here to add this to my saved trials
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
Click here to add this to my saved trials
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
Click here to add this to my saved trials
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Updated: 11/29/2017
FlowTriever Pulmonary Embolectomy Clinical Study
Status: Enrolling
Updated: 11/29/2017
Click here to add this to my saved trials
Interleukin-1 Blockade in Recently Decompensated Heart Failure
Updated: 11/30/2017
Interleukin-1 Blockade in Recently Decompensated Heart Failure: A Randomized Placebo-controlled Double-blinded Study
Status: Enrolling
Updated: 11/30/2017
Interleukin-1 Blockade in Recently Decompensated Heart Failure
Updated: 11/30/2017
Interleukin-1 Blockade in Recently Decompensated Heart Failure: A Randomized Placebo-controlled Double-blinded Study
Status: Enrolling
Updated: 11/30/2017
Click here to add this to my saved trials
Interleukin-1 Blockade in Recently Decompensated Heart Failure
Updated: 11/30/2017
Interleukin-1 Blockade in Recently Decompensated Heart Failure: A Randomized Placebo-controlled Double-blinded Study
Status: Enrolling
Updated: 11/30/2017
Interleukin-1 Blockade in Recently Decompensated Heart Failure
Updated: 11/30/2017
Interleukin-1 Blockade in Recently Decompensated Heart Failure: A Randomized Placebo-controlled Double-blinded Study
Status: Enrolling
Updated: 11/30/2017
Click here to add this to my saved trials
Ranolazine Among Unrevascularized Chronic Stable Angina Patients
Updated: 11/30/2017
Improvement of Subjective Well-Being by Ranolazine Among Unrevascularized Chronic Stable Coronary Artery Disease Patients
Status: Enrolling
Updated: 11/30/2017
Ranolazine Among Unrevascularized Chronic Stable Angina Patients
Updated: 11/30/2017
Improvement of Subjective Well-Being by Ranolazine Among Unrevascularized Chronic Stable Coronary Artery Disease Patients
Status: Enrolling
Updated: 11/30/2017
Click here to add this to my saved trials
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Updated: 11/30/2017
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 11/30/2017
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Updated: 11/30/2017
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 11/30/2017
Click here to add this to my saved trials
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Updated: 11/30/2017
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 11/30/2017
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Updated: 11/30/2017
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 11/30/2017
Click here to add this to my saved trials
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Updated: 11/30/2017
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 11/30/2017
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Updated: 11/30/2017
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 11/30/2017
Click here to add this to my saved trials
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Updated: 11/30/2017
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 11/30/2017
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Updated: 11/30/2017
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 11/30/2017
Click here to add this to my saved trials
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Updated: 11/30/2017
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 11/30/2017
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Updated: 11/30/2017
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 11/30/2017
Click here to add this to my saved trials
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Updated: 11/30/2017
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 11/30/2017
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Updated: 11/30/2017
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 11/30/2017
Click here to add this to my saved trials
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Updated: 11/30/2017
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 11/30/2017
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Updated: 11/30/2017
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 11/30/2017
Click here to add this to my saved trials
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Updated: 11/30/2017
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 11/30/2017
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Updated: 11/30/2017
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 11/30/2017
Click here to add this to my saved trials
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Updated: 11/30/2017
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 11/30/2017
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Updated: 11/30/2017
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 11/30/2017
Click here to add this to my saved trials
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Updated: 11/30/2017
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 11/30/2017
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Updated: 11/30/2017
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 11/30/2017
Click here to add this to my saved trials
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Updated: 11/30/2017
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 11/30/2017
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Updated: 11/30/2017
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 11/30/2017
Click here to add this to my saved trials
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Updated: 11/30/2017
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 11/30/2017
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Updated: 11/30/2017
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 11/30/2017
Click here to add this to my saved trials
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Updated: 11/30/2017
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 11/30/2017
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Updated: 11/30/2017
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 11/30/2017
Click here to add this to my saved trials
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Updated: 11/30/2017
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 11/30/2017
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Updated: 11/30/2017
A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome
Status: Enrolling
Updated: 11/30/2017
Click here to add this to my saved trials